How to Build a Successful Career in HPV Research
Thursday, November 18, 2021
11:45-12:45 EST (GMT-5)
Hear from successful HPV researchers from different disciplines, places, and points in their career talk about the challenges they have faced, strategies to overcome them, and opportunities for career growth in our field. This will be an interactive session with researchers and will end with smaller groups to discuss life after graduate school. Although it is directed to graduate students, postdoctoral fellows, and new investigators in their first years of their careers, all are welcome.
Welcome and Overview
Room stays open after session
Co-facilitator; Open discussion and networking time
Relying on the kindness of strangers
Kate Cuschieri is a consultant clinical scientist in virology and director of the Scottish HPV reference laboratory, funded by the National Health Service. She is lead for the HPV research group at the university of Edinburgh and has an honorary position at the University of Glasgow. She is also a professional clinical advisor for Public Health England. Her key interests are around service delivery, evaluation and improvement with respect to the monitoring and management of HPV infection and associated disease.
Seeing and looking for opportunities: bench to the bedside and back again
Prof Suzanne Garland is a Clinical Microbiologist and Sexual Health Physician who has worked on HPV from epidemiology, clinical HPV vaccine trials for the bivalent and quadrivalent vaccines, and vaccine effectiveness post HPV vaccine rollout in the National Immunisation Program in Australia. She was a founding member of the Society Asia Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN), now over 10 years ago, is the Inaugural and Past President of AOGIN and ongoing Board Advisor. She has 750 peer-reviewed articles in the scientific literature. She is President Elect IPVS [International PapillomaVirus Society], Chair of the Policy Committee IPVS. In 2018 she was a recipient of an Officer of the Order of Australia, AO and in 2019 an Honorary FACOG.
Unconventional Journeys – non-traditional paths to research careers
Elmar A. Joura, M.D., is Associate Professor of Gynecology and Obstetrics at the Medical University of Vienna, General Hospital (AKH), and Comprehensive Cancer Center Vienna, Austria. Dr. Joura graduated from University of Graz, Austria where he subsequently worked at the Department of Pathological Anatomy. After an internship of urology, surgery and internal medicine, he started his training in Obstetrics and Gynecology at the University of Vienna. Since 1997, Dr. Joura is a consultant gynecological oncologist, and is currently running a clinic for colposcopy and vulvar disease, is a consultant for pelvic surgery and was involved in the development of different surgical techniques. Since 2001, he has been an investigator for the quadrivalent and nonvalent HPV vaccine trials, and sits on the publishing committee and the Global Advisory Board. Dr. Joura has published more than 150 articles in peer- review journals and given more than 1000 lectures worldwide.
Women Rock Science: A Pocket Guide for Success in Clinical Academic Research Careers
Rachel Katzenellenbogen is an Associate Professor of Pediatrics and Microbiology and Immunology at Indiana University School of Medicine. She is the co-leader of the Cancer Prevention and Control Program at The Indiana University Simon Comprehensive Cancer Center and the chief of the division of adolescent medicine. She conducts research on high-risk HPV infections and how they drive cancer development and progression. Dr. Katzenellenbogen co-authored a book titled “Women Rock Science: A Pocket Guide for Success in Clinical Academic Research Careers,” and she has a strong interest in mentoring and how to be an excellent mentor.
Laimonis (Lou) Laimans
A Chair’s perspective on recruitment
Dr Laimins’ studies have focused on investigating the life cycle of high-risk human papillomaviruses. His laboratory has used tissue culture methods to grow infectious high-risk HPV virions and to study the differentiation-dependent life cycle of high-risk HPVs. Dr. Laimins received his PhD from the University of Chicago and did postdoctoral work at the NIH. He has been continuously funded by the NCI since 1987 and has been the recipient of an NCI Merit award. He has been a member of several NIH study sections as well as the Board of Scientific Counselors of the NCI and is the author of over 160 manuscripts. Dr. Laimins has trained 24 PhD students as well as over 28 postdoctoral fellows many of whom now hold faculty positions at a variety of institutions around the world. Finally, he is the Chair of the Department of Microbiology-Immunology at the Feinberg School of Medicine of Northwestern University and has served in this capacity for over 18 years.
Being The Only One: Finding A Sense of Belonging in Academic Research
In addition to her position at Dalla Lana School of Public Health, University of Toronto, Dr. Lofters is a family physician at Women’s College Hospital and Chair in Implementation Science at the Peter Gilgan Centre for Women’s Cancers at Women’s College Hospital in partnership with the Canadian Cancer Society. She is an Associate Professor at the University of Toronto in the Department of Family and Community Medicine and senior scientist at the Institute for Clinical Evaluative Sciences. She currently holds a New Investigator Award from CIHR. Her research interests include cancer screening and prevention and health equity, using a broad range of methods.
Learn how to fit a square peg into a round hole: creating your own pathways and training to get to your goal
Dr. Moscicki is a Professor of Pediatrics at UCLA, Chief, Division of Adolescent and Young Adult Medicine, Interim Chief, Division of General Pediatrics, Associate Executive Chair for Clinical Research, and Chair, Clinical Trials Committee for Pediatrics. Dr. Moscicki’s 35+ year career has focused on adolescent gynecology and sexually transmitted infection research with a specific focus in Human Papillomavirus, HIV infection and mucosal immunology. She has served on numerous national and international committees and her work influenced US guidelines on screening and management of abnormal cytology. She was the only pediatrician to become a President of ASCCP. She is also involved in health outcomes in perinatally HIV infected children including sexual risk behaviors, substance use, oral health, microbiomes, and HPV and has worked with numerous Networks on HIV disease in children and adolescents including Adolescent Medicine HIV/AIDS Research Network, Adolescent Therapeutic Network, IMPAACT and PHACS.
Why curiosity, kindness and commitment are critical to building a meaningful career
Gina Ogilvie, MD MSc FCFP DrPH is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at the University of British Columbia in the School of Population and Public Health. She is also Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre. Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally.
Stay curious, alive to opportunity; take measured risks, and collaborate with integrity
Rachel Skinner is a Professor in Pediatrics, in the Faculty of Medicine and Health, Sydney University, and Deputy Director of Wellbeing, Health and Youth (why.org.au), a National Health and Medical Research Council funded Centre of Research Excellence in Adolescent Health. She is a pediatrician specialist in Adolescent and Young Adult Medicine at the Children’s Hospital Westmead in Sydney, in New South Wales and is NSW Ministry of Health’s Senior Clinical Advisor in Youth Health. She has spent much of the last 25 years working as a clinician and researcher in adolescent sexual and reproductive health, spanning medical, public health, psychosocial and ethical aspects of sexual and reproductive health of young people, in Australia and globally. Her main research interest has been human papillomavirus (HPV) vaccine efficacy and effectiveness, as demonstrated through large international multi-centre clinical trials and population-based school vaccination programs. Findings from her research have been translated into policy that have had a global impact on the health of young people.
Maintaining work/life balance: getting over that feeling of doing everything badly
Dr Jo Waller is a Reader in the Cancer Prevention Group at King’s College London where she leads a behavioural science team, and is visiting professor in the Department of Behavioural Science and Health at UCL. Jo’s background is in health psychology and she currently holds a CRUK Career Development Fellowship which aims to use behavioural science to maximise the impact of cervical cancer control policies. Jo has worked in the field of cancer behavioural science for over 20 years, combining qualitative and quantitative methodological approaches to understanding knowledge, attitudes, behaviour and psychological impact across various cancer screening and early diagnosis contexts. She sits on the advisory committees for the NHS breast and cervical screening programmes and works closely with Public Health England to ensure that research findings on screening communication are implemented into the programme.
Li Ping Wong
Spread my wings abroad, amid various opportunities and challenges
Dr. Li Ping Wong received her Ph.D. in Epidemiology from the Faculty of Medicine, University of Malaya, Malaysia in 2004. She is a Professor in the Department of Social and Preventive Medicine in the Faculty of Medicine, University of Malaya, Malaysia. In teaching, Dr. Wong took part in the teaching of the principle of epidemiology and research methodology, both qualitative and quantitative research. In research, Dr. Wong’s research interest has been very diverse throughout the 17 years of her academic career. Most of her research interest has centered almost exclusively on social and behavioral medicine and social epidemiology. In particular to HPV-related research, she started her research on understanding the psychobehavioral of HPV vaccine acceptance in the year 2006 when the HPV vaccine was first available in Malaysia. After a decade when the HPV vaccines are approved for use in China, in the year 2016, she took her research abroad to China. Along with her collaborators, they pioneered several studies on HPV vaccine acceptance in various population groups such as young women, men, married couples, parents, and students in China